📈

AUROPHARMA

shares jump 5%!

💡 According to FT, private equity firm GTCR has struck a $4.8 billion deal to acquire Zentiva. 👉 Earlier, there were market fears that Aurobindo Pharma might take the lead in this acquisition, which had weighed on sentiment. With GTCR stepping in, that concern is off the table. 🔹 Relief rally in the stock 🔹 Short covering visible in F&O trade 🔹 Strong momentum on the upside Investors cheered the news, and Aurobindo stock responded with a solid surge today! 🚀